Logo image of PL

PLANET LABS PBC (PL) Stock Fundamental Analysis

NYSE:PL - New York Stock Exchange, Inc. - US72703X1063 - Common Stock - Currency: USD

6.65  -0.19 (-2.78%)

After market: 6.7 +0.05 (+0.75%)

Fundamental Rating

4

Taking everything into account, PL scores 4 out of 10 in our fundamental rating. PL was compared to 82 industry peers in the Professional Services industry. PL has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, PL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year PL has reported negative net income.
PL had a positive operating cash flow in the past year.
PL had negative earnings in each of the past 5 years.
PL had a negative operating cash flow in each of the past 5 years.
PL Yearly Net Income VS EBIT VS OCF VS FCFPL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

The Return On Assets of PL (-16.18%) is worse than 81.71% of its industry peers.
PL has a worse Return On Equity (-23.95%) than 76.83% of its industry peers.
Industry RankSector Rank
ROA -16.18%
ROE -23.95%
ROIC N/A
ROA(3y)-20.33%
ROA(5y)-21.9%
ROE(3y)-27.72%
ROE(5y)-44.51%
ROIC(3y)N/A
ROIC(5y)N/A
PL Yearly ROA, ROE, ROICPL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

PL's Gross Margin of 58.35% is fine compared to the rest of the industry. PL outperforms 71.95% of its industry peers.
In the last couple of years the Gross Margin of PL has grown nicely.
The Profit Margin and Operating Margin are not available for PL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.26%
GM growth 5YN/A
PL Yearly Profit, Operating, Gross MarginsPL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

8

2. Health

2.1 Basic Checks

PL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PL has more shares outstanding
The number of shares outstanding for PL has been increased compared to 5 years ago.
There is no outstanding debt for PL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PL Yearly Shares OutstandingPL Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 100M 200M 300M
PL Yearly Total Debt VS Total AssetsPL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 3.30 indicates that PL is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.30, PL is doing good in the industry, outperforming 63.41% of the companies in the same industry.
PL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.3
ROIC/WACCN/A
WACC9.04%
PL Yearly LT Debt VS Equity VS FCFPL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 2.10 indicates that PL has no problem at all paying its short term obligations.
PL has a better Current ratio (2.10) than 79.27% of its industry peers.
PL has a Quick Ratio of 2.10. This indicates that PL is financially healthy and has no problem in meeting its short term obligations.
PL has a Quick ratio of 2.10. This is in the better half of the industry: PL outperforms 79.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.1
Quick Ratio 2.1
PL Yearly Current Assets VS Current LiabilitesPL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

PL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.43%, which is quite impressive.
Looking at the last year, PL shows a quite strong growth in Revenue. The Revenue has grown by 9.52% in the last year.
Measured over the past years, PL shows a very strong growth in Revenue. The Revenue has been growing by 20.62% on average per year.
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)9.52%
Revenue growth 3Y23.03%
Revenue growth 5Y20.62%
Sales Q2Q%9.64%

3.2 Future

PL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.86% yearly.
PL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.16% yearly.
EPS Next Y34.49%
EPS Next 2Y25.1%
EPS Next 3Y26.86%
EPS Next 5YN/A
Revenue Next Year11.61%
Revenue Next 2Y16.01%
Revenue Next 3Y18.16%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
PL Yearly Revenue VS EstimatesPL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
PL Yearly EPS VS EstimatesPL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

PL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PL Price Earnings VS Forward Price EarningsPL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PL Per share dataPL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as PL's earnings are expected to grow with 26.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.1%
EPS Next 3Y26.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for PL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLANET LABS PBC

NYSE:PL (7/25/2025, 8:17:06 PM)

After market: 6.7 +0.05 (+0.75%)

6.65

-0.19 (-2.78%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)09-03 2025-09-03/amc
Inst Owners58.03%
Inst Owner Change0.14%
Ins Owners1.9%
Ins Owner Change3.88%
Market Cap2.02B
Analysts82.11
Price Target6.87 (3.31%)
Short Float %4.69%
Short Ratio1.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-58.96%
Min EPS beat(2)-217.93%
Max EPS beat(2)100%
EPS beat(4)3
Avg EPS beat(4)-14.48%
Min EPS beat(4)-217.93%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)4.53%
EPS beat(12)11
Avg EPS beat(12)7.56%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.07%
Min Revenue beat(2)-3.41%
Max Revenue beat(2)3.27%
Revenue beat(4)1
Avg Revenue beat(4)-2.49%
Min Revenue beat(4)-5.77%
Max Revenue beat(4)3.27%
Revenue beat(8)1
Avg Revenue beat(8)-2.54%
Revenue beat(12)3
Avg Revenue beat(12)-1.04%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.27%
PT rev (3m)21.88%
EPS NQ rev (1m)-2.03%
EPS NQ rev (3m)0.67%
EPS NY rev (1m)0.54%
EPS NY rev (3m)24.96%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)0.51%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 8.07
P/FCF N/A
P/OCF 277.59
P/B 4.54
P/tB 7.8
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)0.02
OCFY0.36%
SpS0.82
BVpS1.47
TBVpS0.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.18%
ROE -23.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.35%
FCFM N/A
ROA(3y)-20.33%
ROA(5y)-21.9%
ROE(3y)-27.72%
ROE(5y)-44.51%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.26%
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 109.15%
Cap/Sales 19.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.1
Quick Ratio 2.1
Altman-Z 3.3
F-Score6
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)75.73%
Cap/Depr(5y)61.76%
Cap/Sales(3y)15.4%
Cap/Sales(5y)16.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y34.49%
EPS Next 2Y25.1%
EPS Next 3Y26.86%
EPS Next 5YN/A
Revenue 1Y (TTM)9.52%
Revenue growth 3Y23.03%
Revenue growth 5Y20.62%
Sales Q2Q%9.64%
Revenue Next Year11.61%
Revenue Next 2Y16.01%
Revenue Next 3Y18.16%
Revenue Next 5YN/A
EBIT growth 1Y37.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year83.93%
EBIT Next 3Y42.93%
EBIT Next 5YN/A
FCF growth 1Y64.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y107.42%
OCF growth 3YN/A
OCF growth 5YN/A